A Phase Ib Study of HX008 in Patients With Advanced Solid Tumors

NCT04825392 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: HX008

Sponsor

Taizhou Hanzhong biomedical co. LTD